Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 127.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 22,550
  • Market Cap: £133.58m
  • RiskGrade: 82

Cello Health reports solid growth in 'strong' first half

By Iain Gilbert

Date: Thursday 18 Jul 2019

LONDON (ShareCast) - (Sharecast News) - Advisory group Cello Health anticipates that full-year earnings will "at least be in line with current expectations" after recording growth across the whole business.
Cello said on Thursday that it had experienced a "strong first six months of the year", with good like-for-like growth in overall net revenues and headline profit before tax.

As a result, Cello witnessed "strong growth" in headline earnings per share, leaving it confident of achieving "a successful result in 2019".

Cello Signal, the company's marketing agency, revealed details of its solid start to the year, "with a performance similar to that in the first half of 2018".

The AIM-listed outfit also ended the period with a strong balance sheet, resulting in a net cash position at the end of June.

Looking forward, Cello said: "The group continues to assess suitable acquisitions in line with the strategic objective of further growing the Cello Health brand in the US in particular."

As of 0945 BST, Cello shares had sparked up 4.20% to 124p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50
52 Week Low 96.00
Volume 22,550
Shares Issued 104.77m
Market Cap £133.58m
RiskGrade 82

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.44% below the market average66.44% below the market average66.44% below the market average66.44% below the market average66.44% below the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Price Trend
9.76% below the market average9.76% below the market average9.76% below the market average9.76% below the market average9.76% below the market average
5% below the sector average5% below the sector average5% below the sector average5% below the sector average5% below the sector average
Income
6.78% above the market average6.78% above the market average6.78% above the market average6.78% above the market average6.78% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
32.55% below the market average32.55% below the market average32.55% below the market average32.55% below the market average32.55% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 17-Oct-2019

Time Volume / Share Price
16:20 1,718 @ 128.00p
12:42 300 @ 126.00p
12:14 1,938 @ 128.19p
11:04 7,787 @ 128.25p
10:36 8,307 @ 126.26p

Cello Health Key Personnel

CEO Mark Scott

Top of Page